← Eichor
Condition: Pten Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pten

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Inte
NA · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT05420064A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Phase 1/Phase 2 · 15 location(s) · Terremoto Biosciences Inc. · NCT07109726The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemica
Phase N/A · 9 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT02573636Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Phase 1/Phase 2 · 10 location(s) · SynDevRx, Inc. · NCT05455619Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Phase N/A · 5 location(s) · Boston Children's Hospital · NCT02461446Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06805734Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Video Capsule Examination in Patients With Lynch Syndrome
NA · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT06712095PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
Phase N/A · 1 location(s) · Yale University · NCT06462430A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Comb
Phase 2 · 6 location(s) · VA Office of Research and Development · NCT05593497Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor
Phase 1 · 1 location(s) · Pharosgen Co.,Ltd · NCT06944457Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
Phase 1 · 1 location(s) · Deborah Doroshow · NCT04997993PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer
Phase N/A · 1 location(s) · Atlas University · NCT07297134
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.